Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search

Fibrinolysis

Citations 11-20 of 75 total displayed.

Past content (since Feb 1999):

Vascular Biology
Human Urotensin II Is a Novel Activator of NADPH Oxidase in Human Pulmonary Artery Smooth Muscle Cells
Talija Djordjevic, Rachida S. BelAiba, Steve Bonello, Josef Pfeilschifter, John Hess, and Agnes Görlach
Arterioscler Thromb Vasc Biol 2005;25:519-525; published online before print as doi:10.1161/01.ATV.0000154279.98244.eb [Abstract] [Full text]  

Brief Reviews
Thrombomodulin-Protein C-EPCR System: Integrated to Regulate Coagulation and Inflammation
Marlies Van de Wouwer, Désiré Collen, and Edward M. Conway
Arterioscler Thromb Vasc Biol 2004;24:1374-1383; published online before print as doi:10.1161/01.ATV.0000134298.25489.92 [Abstract] [Full text]  

Thrombosis
NF1 Regulatory Element Functions as a Repressor of Tissue Plasminogen Activator Expression
Nhat-Long Pham, Amy Franzen, and Eugene G. Levin
Arterioscler Thromb Vasc Biol 2004;24:982-987; published online before print as doi:10.1161/01.ATV.0000126679.70877.d0 [Abstract] [Full text]  

Articles
NF1 Regulatory Element Functions as a Repressor of Tissue Plasminogen Activator Expression
Nhat-Long Pham, Amy Franzen, and Eugene G. Levin
Arterioscler Thromb Vasc Biol published March 25, 2004, doi:10.1161/01.ATV.0000126679.70877.d0 [Abstract]  

Vascular Biology
Inhibition of Plasmin Activity by Tranexamic Acid Does Not Influence Inflammatory Pathways During Human Endotoxemia
Rosemarijn Renckens, Sebastiaan Weijer, Alex F. de Vos, Jennie M. Pater, Joost C. Meijers, C. Erik Hack, Marcel Levi, and Tom van der Poll
Arterioscler Thromb Vasc Biol 2004;24:483-488; published online before print as doi:10.1161/01.ATV.0000118280.95422.48 [Abstract] [Full text]  

Thrombosis
Influence of {gamma}' Fibrinogen Splice Variant on Fibrin Physical Properties and Fibrinolysis Rate
J.P. Collet, C. Nagaswami, D.H. Farrell, G. Montalescot, and J.W. Weisel
Arterioscler Thromb Vasc Biol 2004;24:382-386; published online before print as doi:10.1161/01.ATV.0000109748.77727.3e [Abstract] [Full text]  

Articles
Inhibition of Plasmin Activity by Tranexamic Acid Does Not Influence Inflammatory Pathways During Human Endotoxemia
Rosemarijn Renckens, Sebastiaan Weijer, Alex F. de Vos, Jennie M. Pater, Joost C. Meijers, C. Erik Hack, Marcel Levi, and Tom van der Poll
Arterioscler Thromb Vasc Biol published January 22, 2004, doi:10.1161/01.ATV.0000118280.95422.48 [Abstract]  

Articles
Influence of {gamma}' Fibrinogen Splice Variant on Fibrin Physical Properties and Fibrinolysis Rate
J. P. Collet, C. Nagaswami, D. H. Farrell, G. Montalescot, and J. W. Weisel
Arterioscler Thromb Vasc Biol published December 1, 2003, doi:10.1161/01.ATV.0000109748.77727.3e [Abstract]  

Atherosclerosis and Lipoproteins
Coronary Plaque Morphology and Frequency of Ulceration Distant From Culprit Lesions in Patients With Unstable and Stable Presentation
Paul Schoenhagen, Gregg W. Stone, Steven E. Nissen, Cindy L. Grines, John Griffin, Barry S. Clemson, D. Geoffrey Vince, Khaled Ziada, Timothy Crowe, Carolyn Apperson-Hanson, Samir R. Kapadia, and E. Murat Tuzcu
Arterioscler Thromb Vasc Biol 2003;23:1895-1900; published online before print as doi:10.1161/01.ATV.0000084811.73196.1C [Abstract] [Full text]  

Articles
Coronary Plaque Morphology and Frequency of Ulceration Distant From Culprit Lesions In Patients With Unstable and Stable Presentation
Paul Schoenhagen, Gregg W. Stone, Steven E. Nissen, Cindy L. Grines, John Griffin, Barry S. Clemson, D. Geoffrey Vince, Khaled Ziada, Timothy Crowe, Carolyn Apperson-Hanson, Samir R. Kapadia, and E. Murat Tuzcu
Arterioscler Thromb Vasc Biol published July 3, 2003, doi:10.1161/01.ATV.0000084811.73196.1C [Abstract]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8

* Subspecialty Collections Home

* Show  Fibrinolysis
 collections from other journals.

* Related collections:
 Thrombosis
 Anticoagulant mechanisms
 Anticoagulants
 Arterial thrombosis
 Coagulation and fibronolysis
 Coagulation inhibitors
 Coagulation
 Deep vein thrombosis
 Fibrinogen/fibrin
 Fibrinolysis
 Platelet adhesion
 Platelet function inhibitors
 Platelets
 Thrombin
 Thrombophilia
 Thrombosis risk factors